Full delisting from Australia and list on the Nasdaq with new sub holders funding the progress.
It's the prime route to take though a successful EFS may be required to lock in these new funders.
Duravr is an amazing aortic valve and it's ran by an outstanding team and physicians behind it.
Comprehend the long term plan, it's where the real wealth will be created. It ain't going to fall over on ignorance.
The EFS is on track to be presented as Wayne has stated. Those who have said it was being delayed and those touting weakness are just absurd. Ignore them. Stay focused. I have many years to(not too) stay invested here. And your kids will be set for life if you do too(not to)
AVR Price at posting:
$19.10 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)